1. Caminos JE, Nogueiras R, Gaytan F, Pineda R, Gonzalez CR, Barreiro ML, et al. Novel expression and direct effects of adiponectin in the rat testis. Endocrinology. 2008;149(7):3390-3402. [
DOI:10.1210/en.2007-1582] [
PMID]
2. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril. 2009;92(6):1966-1982. [
DOI:10.1016/j.fertnstert.2008.09.018] [
PMID]
3. Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(9):3373-3380. [
DOI:10.1210/jc.2008-0751] [
PMID]
4. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223-1236. [
DOI:10.1056/NEJMra041536] [
PMID]
5. van Santbrink EJ, Fauser BC. Ovulation induction in normogonadotropic anovulation (PCOS). Best Pract Res Clin Endocrinol Metab. 2006;20(2):261-270. [
DOI:10.1016/j.beem.2006.03.002] [
PMID]
6. Dikmen A, Ergenoglu AM, Yeniel AO, Dilsiz OY, Ercan G, Yilmaz H. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):55-59. [
DOI:10.1016/j.ejogrb.2011.09.042] [
PMID]
7. Sabuncu T, Vural H, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Chem. 2001;34(5):407-413. [
DOI:10.1016/S0009-9120(01)00245-4]
8. Cohen G, Riahi Y, Sunda V, Deplano S, Chatgilialoglu C, Ferreri C, et al. Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes. Free Radic Biol Med. 2013;65:978-987. [
DOI:10.1016/j.freeradbiomed.2013.08.163] [
PMID]
9. Setyaningsih Y, Husodo AH, Astuti I. Detection of urinary 8-hydroxydeoxyguanosine (8-OHdG) levels as a biomarker of oxidative DNA damage among home industry workers exposed to chromium. Procedia Environ Sci. 2015;23:290-296. [
DOI:10.1016/j.proenv.2015.01.043]
10. Spritzer MD, Ibler E, Inglis W, Curtis MG. Testosterone and social isolation influence adult neurogenesis in the dentate gyrus of male rats. Neuroscience. 2011;195:180-190. [
DOI:10.1016/j.neuroscience.2011.08.034] [
PMID] [
PMCID]
11. Rafiei S, Bazyar Y, Edalatmanesh MA. Effect of gallic acid and endurance exercise training on BDNF in a model of hippocampal degeneration. Shefaye KhatamShefaye Khatam. 2016;4(1):1-6. [
DOI:10.18869/acadpub.shefa.4.1.1]
12. Tahmasebi F, Movahedin M, Mazaheri Z. Poly cystic ovary model as an elevated oxidative stress factor. J Mazandaran Univ Med Sci. 2015;25(127):82-91.
13. Malek-Mohammadi R, Roghani M, Salami M. The effect of aqueous extracts of Melissa officinalis on the oxidative stress indices in the midbrain tissue. Feyz. 2015;19(1):8-14.
14. Sadoughi SD. Investigation the effect of curcumin on the hormones of pituitary-ovarian axis in Alloxan-induced diabetic rats. J Ardabil Univ Med Sci. 2016;16(4):441-451.
15. Duleba AJ. Medical management of metabolic dysfunction in PCOS. Steroids. 2012;77(4):306-311. [
DOI:10.1016/j.steroids.2011.11.014] [
PMID] [
PMCID]
16. Norouzi T, Ghatreh Samani K, Amini SA. Compare the effects of atorvastatin and omega-3 on index of lipid oxidation in patients with polycystic ovary syndrome. J Shahrekord Univ Med Sci. 2016;18(1):36-44.
17. Petrikova J, Lazurova I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev. 2012;11(6-7):A471-478. [
DOI:10.1016/j.autrev.2011.11.010] [
PMID]
18. Maharaj A. Polycystic ovary syndrome. JEMDSA. 2009;14(2):86-95. [
DOI:10.1080/22201009.2009.10872199]
19. Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. J Obstet Gynaecol. 2004;24(6):613-621. [
DOI:10.1080/01443610400007810] [
PMID]
20. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237-4245. [
DOI:10.1210/jc.2006-0178] [
PMID]
21. Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod. 2013;28(8):2276-2283. [
DOI:10.1093/humrep/det256] [
PMID]
22. Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268-288. [
DOI:10.1093/humupd/dms059] [
PMID]
23. Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011;17(2):171-183. [
DOI:10.1093/humupd/dmq045] [
PMID]
24. Wu C, Lin F, Qiu S, Jiang Z. The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention. PLoS One. 2014;9(6):e99155. [
DOI:10.1371/journal.pone.0099155] [
PMID] [
PMCID]
25. Al-Nozha O, Habib F, Mojaddidi M, El-Bab MF. Body weight reduction and metformin: Roles in polycystic ovary syndrome. Pathophysiology. 2013;20(2):131-137. [
DOI:10.1016/j.pathophys.2013.03.002] [
PMID]
26. Miri M, Karimi Jashni H, Alipour F. Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS. J Ovarian Res. 2014;7:37. [
DOI:10.1186/1757-2215-7-37] [
PMID] [
PMCID]